BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Biofuel
,
Prozac
,
rs3825942
,
VEGFA
,
Angiogenesis
,
HIV infection
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
rna cap
Summary
General Info
Curated Studies
Most Correlated Studies
Lung epithelial cells treated with an RIG-I agonist or INFa-2b
Colorectal cancer HT-29 cells depleted of CAP-D3 and/or infected with S. typhimurium
Polysomal RNA from 483 T-ALL cells treated with cap-dependent translation inhibitor
Dopaminergic neurons (N27) exposed to citrate / PVP capped nanosilver
Whole sphere stage embryos injected with capped NDR1 mRNA
Explore Curated Studies Results
Literature
Most Relevant Literature
Captivating Perplexities of Spinareovirinae 5' RNA Caps.
NADcapPro and circNC: methods for accurate profiling of NAD and non-canonical RNA caps in eukaryotes…
A systems-level mass spectrometry-based technique for accurate and sensitive quantification of the R…
Structural basis for RNA-cap recognition and methylation by the mpox methyltransferase VP39.
Dinucleoside polyphosphates act as 5'-RNA caps in bacteria.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-3…
Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema
A Trial to Evaluate the Safety and Efficacy of CLDN6 CAR-T +/- CLDN6 RNA-LPX
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Leukocyte Morphological Parameters as Prognostic Markers in CAP
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ